103
Views
25
CrossRef citations to date
0
Altmetric
Perspective

Optimizing dendritic cell-based immunotherapy for cancer

, &
Pages 333-345 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michael R Shurin, Melissa Gregory, John C Morris & Anatoli M Malyguine. (2010) Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?. Expert Opinion on Biological Therapy 10:11, pages 1539-1553.
Read now
Yong-Gang Li, Zhi-Ping Wang, Jun-Qiang Tian, Bin-Qiang Tian, Ronald Rodrigues, Pan-Feng Shang & Tao Zhang. (2009) Dendritic Cell Transfected with Secondary Lymphoid-Tissue Chemokine and/or Interleukin-2 Gene-Enhanced Cytotoxicity of T-Lymphocyte in Human Bladder Tumor Cell S In Vitro. Cancer Investigation 27:9, pages 909-917.
Read now

Articles from other publishers (23)

Yike Hou, Zhe Tang, Jabeen Farheen, Madiha Saeed, Lijia Luo, Wenzi Ren, Dandan Luo, Asim Mushtaq, Ruibo Zhao, Jian Ge, Zhangsen Yu, Yao Li, M. Zubair Iqbal & Xiangdong Kong. (2023) Ovalbumin-loaded paramagnetic nano-triangles for enhanced dendritic cell stimulation, T1-MR imaging, and antitumor immunity. Journal of Materials Science & Technology 148, pages 123-137.
Crossref
Qianqian Zhou, Hongjing Gu, Sujing Sun, Yulong Zhang, Yangyang Hou, Chenyan Li, Yan Zhao, Ping Ma, Liping Lv, Subi Aji, Shihui Sun, Xiaohui Wang & Linsheng Zhan. (2021) Large‐Sized Graphene Oxide Nanosheets Increase DC–T‐Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS‐CoV‐2. Advanced Materials 33:40, pages 2102528.
Crossref
Derek Hoi-Hang Ho & Roger Hoi-Fung Wong. (2018) TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine. Blood Advances 2:14, pages 1664-1679.
Crossref
Eonju Oh, Jung-Eun Oh, JinWoo Hong, YoonHo Chung, Yunki Lee, Ki Dong Park, Sungwan Kim & Chae-Ok Yun. (2017) Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy. Journal of Controlled Release 259, pages 115-127.
Crossref
A. A. Keskinov, M. R. Shurin, V. M. Bukhman & Z. S. Shprakh. (2017) IMPACT OF TUMOR-DERIVED FACTORS ON DENDRITIC CELLS IN CANCER. Russian Journal of Biotherapy 16:1, pages 12-23.
Crossref
Jinbao Zong, Anton A. Keskinov, Galina V. Shurin & Michael R. Shurin. (2016) Tumor-derived factors modulating dendritic cell function. Cancer Immunology, Immunotherapy 65:7, pages 821-833.
Crossref
Michael R. Shurin & Anton A. Keskinov. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 499 511 .
YING LI & JUANJUAN DING. (2015) Optimized generation of survivin-specific cytotoxic T lymphocytes against lung cancer. Molecular Medicine Reports 12:2, pages 2169-2174.
Crossref
Arpit Bhargava, Dinesh Mishra, Smita Banerjee & Pradyumna Kumar Mishra. (2012) Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation. Immunotherapy 4:7, pages 703-718.
Crossref
Joanna Rossowska, Elżbieta Pajtasz-Piasecka, Oliwia Ryśnik, Justyna Wojas, Agnieszka Krawczenko, Anna Szyda & Danuta Duś. (2011) Generation of antitumor response by IL-2-transduced JAWS II dendritic cells. Immunobiology 216:10, pages 1074-1084.
Crossref
Jing-Hua Huang, Song-Nan Zhang, Kyung-Ju Choi, Il-Kyu Choi, Joo-Hang Kim, Mingul Lee, Hoguen Kim & Chae-Ok Yun. (2010) Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL. Molecular Therapy 18:2, pages 264-274.
Crossref
Ramon Kaneno, Galina V Shurin, Irina L Tourkova & Michael R Shurin. (2009) Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations. Journal of Translational Medicine 7:1.
Crossref
Cornelia Wurzenberger, Viktor H. Koelzer, Susanne Schreiber, David Anz, Angelika M. Vollmar, Max Schnurr, Stefan Endres & Carole Bourquin. (2008) Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo. Cancer Immunology, Immunotherapy 58:6, pages 901-913.
Crossref
Michael R. Shurin, Alla I. Potapovich, Yulia Y. Tyurina, Irina L. Tourkova, Galina V. Shurin & Valerian E. Kagan. (2009) Recognition of Live Phosphatidylserine-Labeled Tumor Cells by Dendritic Cells: A Novel Approach to Immunotherapy of Skin Cancer. Cancer Research 69:6, pages 2487-2496.
Crossref
Brian J. Morrison, Jason C. Steel, Melissa Gregory, John C. Morris & Anatoli M. Malyguine. 2009. Dendritic Cells in Cancer. Dendritic Cells in Cancer 347 363 .
Ezra D. Mirvish, Rebecca G. Pomerantz, Louis D. Falo & Larisa J. Geskin. 2009. Dendritic Cells in Cancer. Dendritic Cells in Cancer 309 330 .
Zoya R. Yurkovetsky & Ghena N. Yurkovetsky. 2009. Dendritic Cells in Cancer. Dendritic Cells in Cancer 271 289 .
Galina V. Shurin, Neil Amina & Michael R. Shurin. 2009. Dendritic Cells in Cancer. Dendritic Cells in Cancer 201 216 .
Juliana Moreira de Sousa-CanavezDewton de Moraes-VasconcelosElaine Cristina CornetaKatia R.M. LeiteLuiz H. Camara-Lopes. (2008) Evaluation of Dendritic Cell–Tumor Cell Hybrid Vaccine Storage. Biopreservation and Biobanking 6:4, pages 285-288.
Crossref
Galina V. Shurin, Irina L. Tourkova & Michael R. Shurin. (2008) Low-dose Chemotherapeutic Agents Regulate Small Rho GTPase Activity in Dendritic Cells. Journal of Immunotherapy 31:5, pages 491-499.
Crossref
Jelena M. Janjic, Mangala Srinivas, Deepak K. K. Kadayakkara & Eric T. Ahrens. (2008) Self-delivering Nanoemulsions for Dual Fluorine-19 MRI and Fluorescence Detection. Journal of the American Chemical Society 130:9, pages 2832-2841.
Crossref
Morikazu Onji & Sk. Md. Fazle Akbar. 2008. Dendritic Cells in Clinics. Dendritic Cells in Clinics 105 140 .
Irina O. Chikileva, Natalia Yu. Anisimova, Olga V. Lebedinskaya, Mikhail V. Kiselevsky & Vyacheslav M. Abramov. 2008. Atlas Effectors of Anti-Tumor Immunity. Atlas Effectors of Anti-Tumor Immunity 111 159 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.